IBDEI30G ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,48078,0)
;;=E34.9^^185^2417^57
;;^UTILITY(U,$J,358.3,48078,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48078,1,3,0)
;;=3^Endocrine Disorder,Unspec
;;^UTILITY(U,$J,358.3,48078,1,4,0)
;;=4^E34.9
;;^UTILITY(U,$J,358.3,48078,2)
;;=^5002777
;;^UTILITY(U,$J,358.3,48079,0)
;;=R62.7^^185^2417^58
;;^UTILITY(U,$J,358.3,48079,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48079,1,3,0)
;;=3^Failure to Thrive,Adult
;;^UTILITY(U,$J,358.3,48079,1,4,0)
;;=4^R62.7
;;^UTILITY(U,$J,358.3,48079,2)
;;=^322019
;;^UTILITY(U,$J,358.3,48080,0)
;;=R63.3^^185^2417^59
;;^UTILITY(U,$J,358.3,48080,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48080,1,3,0)
;;=3^Feeding Difficulty
;;^UTILITY(U,$J,358.3,48080,1,4,0)
;;=4^R63.3
;;^UTILITY(U,$J,358.3,48080,2)
;;=^5019541
;;^UTILITY(U,$J,358.3,48081,0)
;;=E87.8^^185^2417^60
;;^UTILITY(U,$J,358.3,48081,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48081,1,3,0)
;;=3^Fluid & Electrolyte Balance Disorder NEC
;;^UTILITY(U,$J,358.3,48081,1,4,0)
;;=4^E87.8
;;^UTILITY(U,$J,358.3,48081,2)
;;=^5003026
;;^UTILITY(U,$J,358.3,48082,0)
;;=E87.70^^185^2417^61
;;^UTILITY(U,$J,358.3,48082,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48082,1,3,0)
;;=3^Fluid Overload,Unspec
;;^UTILITY(U,$J,358.3,48082,1,4,0)
;;=4^E87.70
;;^UTILITY(U,$J,358.3,48082,2)
;;=^5003023
;;^UTILITY(U,$J,358.3,48083,0)
;;=R73.01^^185^2417^75
;;^UTILITY(U,$J,358.3,48083,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48083,1,3,0)
;;=3^Impaired Fasting Glucose
;;^UTILITY(U,$J,358.3,48083,1,4,0)
;;=4^R73.01
;;^UTILITY(U,$J,358.3,48083,2)
;;=^5019561
;;^UTILITY(U,$J,358.3,48084,0)
;;=R73.02^^185^2417^76
;;^UTILITY(U,$J,358.3,48084,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48084,1,3,0)
;;=3^Impaired Oral Glucose Tolerance
;;^UTILITY(U,$J,358.3,48084,1,4,0)
;;=4^R73.02
;;^UTILITY(U,$J,358.3,48084,2)
;;=^5019562
;;^UTILITY(U,$J,358.3,48085,0)
;;=E83.119^^185^2417^62
;;^UTILITY(U,$J,358.3,48085,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48085,1,3,0)
;;=3^Hemochromatosis,Unspec
;;^UTILITY(U,$J,358.3,48085,1,4,0)
;;=4^E83.119
;;^UTILITY(U,$J,358.3,48085,2)
;;=^5002995
;;^UTILITY(U,$J,358.3,48086,0)
;;=E83.52^^185^2417^63
;;^UTILITY(U,$J,358.3,48086,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48086,1,3,0)
;;=3^Hypercalcemia
;;^UTILITY(U,$J,358.3,48086,1,4,0)
;;=4^E83.52
;;^UTILITY(U,$J,358.3,48086,2)
;;=^59932
;;^UTILITY(U,$J,358.3,48087,0)
;;=E11.65^^185^2417^20
;;^UTILITY(U,$J,358.3,48087,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48087,1,3,0)
;;=3^Diabetes Type 2 w/ Hyperglycemia
;;^UTILITY(U,$J,358.3,48087,1,4,0)
;;=4^E11.65
;;^UTILITY(U,$J,358.3,48087,2)
;;=^5002663
;;^UTILITY(U,$J,358.3,48088,0)
;;=R73.9^^185^2417^64
;;^UTILITY(U,$J,358.3,48088,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48088,1,3,0)
;;=3^Hyperglycemia,Unspec
;;^UTILITY(U,$J,358.3,48088,1,4,0)
;;=4^R73.9
;;^UTILITY(U,$J,358.3,48088,2)
;;=^5019564
;;^UTILITY(U,$J,358.3,48089,0)
;;=E87.5^^185^2417^66
;;^UTILITY(U,$J,358.3,48089,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48089,1,3,0)
;;=3^Hyperkalemia
;;^UTILITY(U,$J,358.3,48089,1,4,0)
;;=4^E87.5
;;^UTILITY(U,$J,358.3,48089,2)
;;=^60041
;;^UTILITY(U,$J,358.3,48090,0)
;;=E83.41^^185^2417^67
;;^UTILITY(U,$J,358.3,48090,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48090,1,3,0)
;;=3^Hypermagnesemia
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI30G 3754 printed Oct 16, 2024@18:40:10 Page 2
IBDEI30G ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,48078,0)
+2 ;;=E34.9^^185^2417^57
+3 ;;^UTILITY(U,$J,358.3,48078,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,48078,1,3,0)
+6 ;;=3^Endocrine Disorder,Unspec
+7 ;;^UTILITY(U,$J,358.3,48078,1,4,0)
+8 ;;=4^E34.9
+9 ;;^UTILITY(U,$J,358.3,48078,2)
+10 ;;=^5002777
+11 ;;^UTILITY(U,$J,358.3,48079,0)
+12 ;;=R62.7^^185^2417^58
+13 ;;^UTILITY(U,$J,358.3,48079,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,48079,1,3,0)
+16 ;;=3^Failure to Thrive,Adult
+17 ;;^UTILITY(U,$J,358.3,48079,1,4,0)
+18 ;;=4^R62.7
+19 ;;^UTILITY(U,$J,358.3,48079,2)
+20 ;;=^322019
+21 ;;^UTILITY(U,$J,358.3,48080,0)
+22 ;;=R63.3^^185^2417^59
+23 ;;^UTILITY(U,$J,358.3,48080,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,48080,1,3,0)
+26 ;;=3^Feeding Difficulty
+27 ;;^UTILITY(U,$J,358.3,48080,1,4,0)
+28 ;;=4^R63.3
+29 ;;^UTILITY(U,$J,358.3,48080,2)
+30 ;;=^5019541
+31 ;;^UTILITY(U,$J,358.3,48081,0)
+32 ;;=E87.8^^185^2417^60
+33 ;;^UTILITY(U,$J,358.3,48081,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,48081,1,3,0)
+36 ;;=3^Fluid & Electrolyte Balance Disorder NEC
+37 ;;^UTILITY(U,$J,358.3,48081,1,4,0)
+38 ;;=4^E87.8
+39 ;;^UTILITY(U,$J,358.3,48081,2)
+40 ;;=^5003026
+41 ;;^UTILITY(U,$J,358.3,48082,0)
+42 ;;=E87.70^^185^2417^61
+43 ;;^UTILITY(U,$J,358.3,48082,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,48082,1,3,0)
+46 ;;=3^Fluid Overload,Unspec
+47 ;;^UTILITY(U,$J,358.3,48082,1,4,0)
+48 ;;=4^E87.70
+49 ;;^UTILITY(U,$J,358.3,48082,2)
+50 ;;=^5003023
+51 ;;^UTILITY(U,$J,358.3,48083,0)
+52 ;;=R73.01^^185^2417^75
+53 ;;^UTILITY(U,$J,358.3,48083,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,48083,1,3,0)
+56 ;;=3^Impaired Fasting Glucose
+57 ;;^UTILITY(U,$J,358.3,48083,1,4,0)
+58 ;;=4^R73.01
+59 ;;^UTILITY(U,$J,358.3,48083,2)
+60 ;;=^5019561
+61 ;;^UTILITY(U,$J,358.3,48084,0)
+62 ;;=R73.02^^185^2417^76
+63 ;;^UTILITY(U,$J,358.3,48084,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,48084,1,3,0)
+66 ;;=3^Impaired Oral Glucose Tolerance
+67 ;;^UTILITY(U,$J,358.3,48084,1,4,0)
+68 ;;=4^R73.02
+69 ;;^UTILITY(U,$J,358.3,48084,2)
+70 ;;=^5019562
+71 ;;^UTILITY(U,$J,358.3,48085,0)
+72 ;;=E83.119^^185^2417^62
+73 ;;^UTILITY(U,$J,358.3,48085,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,48085,1,3,0)
+76 ;;=3^Hemochromatosis,Unspec
+77 ;;^UTILITY(U,$J,358.3,48085,1,4,0)
+78 ;;=4^E83.119
+79 ;;^UTILITY(U,$J,358.3,48085,2)
+80 ;;=^5002995
+81 ;;^UTILITY(U,$J,358.3,48086,0)
+82 ;;=E83.52^^185^2417^63
+83 ;;^UTILITY(U,$J,358.3,48086,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,48086,1,3,0)
+86 ;;=3^Hypercalcemia
+87 ;;^UTILITY(U,$J,358.3,48086,1,4,0)
+88 ;;=4^E83.52
+89 ;;^UTILITY(U,$J,358.3,48086,2)
+90 ;;=^59932
+91 ;;^UTILITY(U,$J,358.3,48087,0)
+92 ;;=E11.65^^185^2417^20
+93 ;;^UTILITY(U,$J,358.3,48087,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,48087,1,3,0)
+96 ;;=3^Diabetes Type 2 w/ Hyperglycemia
+97 ;;^UTILITY(U,$J,358.3,48087,1,4,0)
+98 ;;=4^E11.65
+99 ;;^UTILITY(U,$J,358.3,48087,2)
+100 ;;=^5002663
+101 ;;^UTILITY(U,$J,358.3,48088,0)
+102 ;;=R73.9^^185^2417^64
+103 ;;^UTILITY(U,$J,358.3,48088,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,48088,1,3,0)
+106 ;;=3^Hyperglycemia,Unspec
+107 ;;^UTILITY(U,$J,358.3,48088,1,4,0)
+108 ;;=4^R73.9
+109 ;;^UTILITY(U,$J,358.3,48088,2)
+110 ;;=^5019564
+111 ;;^UTILITY(U,$J,358.3,48089,0)
+112 ;;=E87.5^^185^2417^66
+113 ;;^UTILITY(U,$J,358.3,48089,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,48089,1,3,0)
+116 ;;=3^Hyperkalemia
+117 ;;^UTILITY(U,$J,358.3,48089,1,4,0)
+118 ;;=4^E87.5
+119 ;;^UTILITY(U,$J,358.3,48089,2)
+120 ;;=^60041
+121 ;;^UTILITY(U,$J,358.3,48090,0)
+122 ;;=E83.41^^185^2417^67
+123 ;;^UTILITY(U,$J,358.3,48090,1,0)
+124 ;;=^358.31IA^4^2
+125 ;;^UTILITY(U,$J,358.3,48090,1,3,0)
+126 ;;=3^Hypermagnesemia
